EU panel recommends suspension of risky bone disease drug

[riky]

EU panel recommends suspension of risky bone disease drug

LONDON (Reuters) - European regulators have recommended suspending a popular bone-building drug made by unlisted French firm Servier because of the risk of serious heart problems and blood clots. The European Medicines Agency had already restricted the use of Protelos - also known as Osseor or strontium ranelate - last April but its pharmacovigilance committee said on Friday the drug should no longer be used to treat osteoporosis at all. ...

Source: You are not allowed to view links. Register or Login